Shriram Revankar insider trades: Dolby Laboratories (DLB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shriram reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | DLB | ↓ Sell | 3,000 | $54.90 | $165K | Direct | May 19, 2026 (4d) |
| Feb 17, 2026 | DLB | ↓ Sell | 3,000 | $66.14 | $198K | Direct | Feb 17, 2026 (0d) |
| Nov 21, 2025 | DLB | ↓ Sell | 3,000 | $65.55 | $197K | Direct | Nov 24, 2025 (3d) |
| Aug 22, 2025 | DLB | ↓ Sell | 7,000 | $74.92 | $524K | Direct | Aug 26, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DLB insiders
Open-market trades in the last 12 months
About Shriram Revankar's insider trades
Shriram Revankar is SVP, Advanced Technology Group at Dolby Laboratories (DLB). Since Aug 22, 2025, Shriram has reported no open-market purchases and 4 sales worth $1.1M on SEC Form 4. In the last 12 months: 3 sales ($560K).
Their filings also include shares withheld for taxes (7 filings), grants and awards (5 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DLB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.